Nanobiotix Financials
| NANO Stock | EUR 3.22 0.11 3.30% |
Nanobiotix |
Understanding current and past Nanobiotix Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Nanobiotix's financial statements are interrelated, with each one affecting the others. For example, an increase in Nanobiotix's assets may result in an increase in income on the income statement.
Please note, the presentation of Nanobiotix's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nanobiotix's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Nanobiotix's management manipulating its earnings.
Nanobiotix Stock Summary
Nanobiotix competes with Vetoquinol, Trigano SA, Biomerieux, Sartorius Stedim, and Ipsen SA. Nanobiotix SA, a late stage clinical company, develops and sells nanomedicine for the treatment of cancer worldwide. Nanobiotix SA was incorporated in 2003 and is headquartered in Paris, France. NANOBIOTIX operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 102 people.| Foreign Associates | |
| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0011341205 |
| Business Address | 60 rue de |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Major |
| Benchmark | Dow Jones Industrial |
| Website | www.nanobiotix.com |
| Phone | 33 1 40 26 04 70 |
| Currency | EUR - Euro |
You should never invest in Nanobiotix without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Nanobiotix Stock, because this is throwing your money away. Analyzing the key information contained in Nanobiotix's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Nanobiotix Key Financial Ratios
Nanobiotix's financial ratios allow both analysts and investors to convert raw data from Nanobiotix's financial statements into concise, actionable information that can be used to evaluate the performance of Nanobiotix over time and compare it to other companies across industries.Nanobiotix Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nanobiotix's current stock value. Our valuation model uses many indicators to compare Nanobiotix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanobiotix competition to find correlations between indicators driving Nanobiotix's intrinsic value. More Info.Nanobiotix SA is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanobiotix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanobiotix's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nanobiotix SA Systematic Risk
Nanobiotix's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nanobiotix volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Nanobiotix SA correlated with the market. If Beta is less than 0 Nanobiotix generally moves in the opposite direction as compared to the market. If Nanobiotix Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nanobiotix SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nanobiotix is generally in the same direction as the market. If Beta > 1 Nanobiotix moves generally in the same direction as, but more than the movement of the benchmark.
Nanobiotix November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Nanobiotix help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nanobiotix SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nanobiotix SA based on widely used predictive technical indicators. In general, we focus on analyzing Nanobiotix Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nanobiotix's daily price indicators and compare them against related drivers.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 18.72 | |||
| Value At Risk | (5.04) | |||
| Potential Upside | 4.49 |
Complementary Tools for Nanobiotix Stock analysis
When running Nanobiotix's price analysis, check to measure Nanobiotix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobiotix is operating at the current time. Most of Nanobiotix's value examination focuses on studying past and present price action to predict the probability of Nanobiotix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobiotix's price. Additionally, you may evaluate how the addition of Nanobiotix to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |